Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Omeros is a US-based biopharmaceutical company specializing in the development of innovative therapeutics for inflammatory diseases, coagulopathies, and neurological disorders. Through cutting-edge drug discovery research, Omeros addresses critical, unmet medical needs on a global scale.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Omeros is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Omeros last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at 0.15 USD.
Across its last 3 earnings reports, Omeros stock moved by ±16.2% on average the following day. The largest reaction was +26.6% on 08/12/2026; 2 of 3 reactions were positive.
Omeros has beaten analyst EPS estimates in 6 of its last 6 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.